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Summary Fresh leukaemia cells from the peripheral blood of 6 patients with B-chronic lymphocytic
leukaemia (CLL) were cultured in the continuous presence of the phorbolester 12-0-tetradecanoylphorbol 13-
acetate (TPA) for in vitro induction of differentiation. Upon treatment with TPA the cells showed distinct
morphological changes consisting of cytoplasmic and nuclear enlargement, vacuolisation and protrusion of
cytoplasm, eccentric location of nuclei with perinuclear clear zones, and oval to elongated cell forms.
Isoenzyme profiles of the enzymes carboxylic esterase, acid phosphatase, hexosaminidase and lactate
dehydrogenase (LDH) were analysed by isoelectric focusing on polyacrylamide gels. An increase in the
number and in the staining intensity of isoenzymes were observed for all 4 enzymes in the TPA-exposed cells
indicating a maturation along the B cell pathway. TPA triggered the new expression of the tartrate-resistant
acid phosphatase isoenzyme, a marker of hairy cell leukaemia (HCL) cells, and of the hexosaminidase I
isoenzyme, a marker of multiple myeloma cells. The induced phenotypic changes are suggestive of
differentiation to stages corresponding to those of HCL cells or 'pre-plasma cells'.
Cases of chronic lymphocytic leukaemia (CLL)
represent predominantly monoclonal proliferations
of malignant B-lymphocytes. The neoplastic cells
are characterised by a monoclonal expression of
surface immunoglobulins, commonly IgM and often
co-expressed with IgD, with light chains restricted
to either kappa or lambda (Gordon et al., 1983).
CLL cells seem to be arrested at a stage in the B-
cell differentiation corresponding to rather
immature B-lymphocytes, but are clearly more
differentiated than pre B-cells with their malignant
counterparts cALL (common acute lymphoblastic
leukaemia), pre B-ALL and B-ALL cells (Gordon
et al., 1983). The phorbolester 12-0-tetradecanoyl-
phorbol 13-acetate (TPA) could induce the
differentiation of B-CLL cells in vitro (Toetterman
et al., 1980). Several investigators have found
morphological, functional, cytochemical and
immunological changes in B-CLL cells caused by
treatment with TPA (Gordon et al., 1984; Dufer &
Bernard, 1984; Toetterman et al., 1981a,b; Deegan
& Maeda, 1984).
In this report we describe the morphological and
isoenzymatic changes in B-CLL cells which were
exposed to different concentrations of TPA. The
isoenzymes of carboxylic esterase (E.C.3.1.1.1), acid
phosphatase (E.C.3.1.3.2), hexosaminidase (=beta-
N-acetylglucosaminidase, E.C.3.2.1.30) and lactate
dehydrogenase (LDH, E.C.1.1.1.27) were separated
by analytical isoelectric focusing on horizontal
thin-layer polyacrylamide gels. The qualitative
demonstration of (iso-)enzyme alterations can
reveal more details and isoenzyme profiles represent
more sensitive parameters of induced biochemical
changes than the quantitative measurement of total
enzymatic activities (Drexler et al., 1984).
Materials and methods
Patients
Six patients with B-CLL were studied. The
diagnosis of B-CLL was established on the basis of
lymphocytosis and typical morphology of the cells
and immunological surface marker analysis. Age,
sex and WBC of the patients are shown in Table I.
Freshly obtained peripheral blood lymphocytes
were separated by Ficoll-Hypaque density gradient
centrifugation.
Surface marker analysis
Phenotyping of the cells was performed as
described in detail earlier (Drexler et al., 1985a).
Goat anti-human antisera (Cappel Lab.,
Cochranville, PA, USA) to human immunoglobulin
chains labelled with fluorescein-isothiocyanate
(FITC) were used to determine the isotype of the
monoclonal populations in direct immuno-
fluorescence. The number of T lymphocytes, Ia-
like/HLA-Dr antigen (la) positive cells, common
ALL-antigen (cALLA) positive cells and
myelomonocytic cells were determined by staining
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Table I Clinical and laboratory findings of CLL patients at the time of study
Rosettes
Age WBC Pan-T Ia cALLA Myeloid-Ag
Patient (yr) Sex (x1091-1)
Isotype (Leu-J)a (BA-4) (J-5) (MSC-2) Etb EAc
J.P. 60 M 96 kappa DMd >goe >90 0 <5 10 40
S.F. 65 M 176 lambda DM >90 >90 0 <5 <5 10
C.S. 64 M 80 lambda DM >90 >90 0 <5 <5 30
C.H. 85 M 322 kappa DM >90 >90 0 <5 5 20
A.H. 66 M 410 kappa DM >90 >90 0 <5 <5 40
T.L. 64 M 400 kappa DM >90 >90 0 <5 <5 40
aLeu-I also reacts with B-CLL cells; bEt detects pan-T cells; CEA detects Fc-receptor positive cells; dD:IgD;
M:IgM; eThe results are expressed as percent positive cells.
with the monoclonal antibodies (MoAbs) Leu-1
(Pan-T; Becton-Dickinson, Mountain View, CA,
USA), BA-4 (Ia; Hybritech, San Diego, CA, USA),
J-5 (cALLA; Coulter Immunology, Hialeah, FL,
USA) and MCS-2 (detecting an antigen specific for
myelomonocytic cells; Drexler et al., 1985a).
MoAbs were investigated in indirect immunofluore-
scence assays using FITC-conjugated IgG F(ab)'
goat anti-murine antibodies (Meloy, Springfield,
VA, USA) as secondary reagents, Cells were
incubated with the primary reagent at saturating
concentrations for 30min at room temperature, and
in cases of indirect immunofluorescence for another
30min with the secondary reagents at excess
concentrations. At least 200 cells were examined
under an epi-immunofluorescence microscope.
Erythrocyte rosette tests were performed by
centrifuging and incubating the cells with untreated
sheep erythrocytes (Et for Pan-T cells) and rabbit
IgG anti-bovine antibody coated bovine erythro-
cytes (EA for detection of Fc-receptor positive cells)
for 2h at 4°C and for 1.5h at room temperature,
respectively.
Induction experiments
Cells were resuspended in 50ml RPMI 1640
medium containing 5% heat-inactivated foetal calf
serum at a concentration of 1.0 x 106 cellsml-1.
TPA was added at concentrations of 10-8M and
10-9M TPA. Control cultures without TPA and
TPA-exposed cultures were incubated at 37°C in a
humidified 5% C02-atmosphere without further
feeding with fresh medium. Cells were harvested
and examined for the above described parameters
at 0, 48, 96, 144 and 192h. Experiments were
performed in duplicate. Cell viability was assessed
by trypan blue dye exclusion test and cell count in
suspension by hematocytometer.
Morphology
The morphological changes of the cells were
observed on cytospin slide preparations made from
all treated and control cultures. Cells were stained
by standard Wright-Giemsa stain.
Isoelectricfocusing
After harvest, cells were resuspended in a tris-buffer
of pH7.4 at a concentration of 5 x 107cellsml-1.
Enzymes were extracted by three cycles of
freezing/thawing and enzymatic activities were
solubilized by addition of 1% Triton X 100. After
centrifugation, the supernatant containing all
enzymatic activities was used for separation of
isoenzymes. Aliquots of 'enzyme solution' referring
to equal numbers of cells were applied.
Analytical isoelectric focusing was performed on
horizontal thin-layer polyacrylamide gels containing
4.8% (w/v) acrylamide/bisacrylamide, 12.5% (w/v)
sucrose, 0.015% (w/v) ammoniumpersulfate/ribo-
flavin and 0.1% (v/v) tetramethylethylene diamine.
Two per cent (w/v) ampholyt of pH2-11 (Serva,
Heidelberg, FRG) used for the enzymes esterase,
acid phosphatase, LDH, and ampholyte of pH3-10
(Sigma, St. Louis, MO, USA) for hexosaminidase
were added to the gel matrix. Runs were carried
out for 1 h at constant power of 30W, voltage
limited to 1400V, cooling of 50C using a LKB-
Multiphor/Power Supply unit (LKB, Bromma,
Sweden). Isoenzymes were visualised directly on the
gels immediately after isoelectric focusing.
Staining techniques
Isoenzymes were stained according to modified
histo-cytochemical staining methods.
Carboxylic esterase Phosphate-buffer of pH7.2,
alpha-naphthylacetate dissolved in acetone and FastINDUCED DIFFERENTIATION OF B-CLL CELLS
Blue RR; staining for 1 h at room temperature
(Drexler et al., 1985a). One esterase isoenzyme
which is specific for monocytes can be completely
and selectively inhibited by addition of sodium
fluoride to the staining solution (Drexler et al.,
1985a).
Acid phosphatase Naphthol-AS-Bi-phosphate dis-
solved in dimethylformamide, hexazotized pararo-
saniline and barbituric acid-sodium acetate buffer
of pH5.0; staining for 3.5h at room temperature
(Drexler et al., 1985b). The tartrate-resistant acid
phosphatase (TracP) isoenzyme was identified by
addition of sodium tartrate to the staining bath as
it was resistant whereas all other isoenzymes were
inhibited (Drexler et al., 1985b)
Hexosaminidase Naphthol-AS-Bi-N-acetyl-beta-D-
glucosaminide dissolved in ethyleneglycol mono-
methyl ether, Fast Garnet GBC and citrate-buffer
of pH4.5; staining for 1.5h at 37°C (Drexler et al.,
1985c). Maximally 3 isoenzymes (A, I, B) can be
detected by this methodology (Drexler et al., 1985c;
Gaedicke & Drexler, 1984).
LDH Sodium lactate, nicotinamide adenine
dinucleotide, NaCl, MgCl2, phosphate-buffer of
pH7.4, nitro-blue tetrazolium and phenazine
methosulfate; staining for 20min at room
temperature (Drexler et al., 1985d). The following
isoenzymes and isoenzyme components could be
maximally detected after isoelectric focusing 1, 2, 3,
4 (a and b), 5 (a, b and c) (Drexler et al., 1985d).
Results
Cell counts
The number of viable cells decreased strongly in the
control cultures of all cases studied (Figure 1).
However, the decrease in cell counts was less
pronounced in TPA-treated cultures as compared to
the controls. In most cases, at the concentration of
10-8M TPA, the viability of cultures dropped
slower than at 10 9M TPA. Figure 1 which is
representative for all cases shows the viable cell
counts of TPA-treated and control cells from one
case during in vitro culture (Figure 1).
Morphologicalfeatures
The fresh cell populations and the untreated control
cells were predominantly homogenous in cell size
and shape consisting of small lymphocytes typical
of CLL with scanty cytoplasm, small round nuclei,
and mostly condensed chromatin. Most of the
TPA-exposed cells became enlarged with relatively
abundant cytoplasm (Figure 2). The large cells were
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Figure 1 Viable cell counts of control and TPA-
treated CLL cells (case T.L.) during in vitro culture at
days 0-8 (shown are mean values of two parallel
experiments of the same case).
first heterogeneous in their morphology, and cell
shapes became highly variable. A shift in the shape
of cells was observed from round to oval or
elongated forms. Cytoplasmic vacuolisation,
cytoplasmic blebs and protrusions, and undulation
of the membrane was seen in the TPA-treated
cultures. The increase in cell size involved
cytoplasmic as well as nuclear enlargement. In most
cells the nuclei became larger, less condensed and
eccentrically located. Perinuclear clearer zones
could be distinguished in TPA-treated cells.
Whereas the TPA-treated cultures showed strong
heterogeneity regarding cell sizes and other induced
features at days 04 with a significant percentage of
small, round, unaltered 'B-CLL-like' cells present,
the picture became more homogenous at days 6-8
when these obviously non-responsive cells were no
longer seen. We did not detect mitosis in the cell
cultures.
Isoenzyme analysis
The characteristics of the isoenzymes studied and
their expression in normal cells and fresh or
cultured leukaemia cells have been described in
detail earlier (Drexler et al., 1985a,b,c,d; Gaedicke
& Drexler, 1984).
Carboxylic esterase TPA caused a stronger
staining intensity of most isoenzymes and the new
expression of one isoenzyme leading to an
isoenzyme profile as seen in B leukaemia cell lines
arrested at intermediate to late stages along the B
B
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Figure 2 (a) Fresh (day 0) CLL cells (case J.P.). (b) CLL cells (case S.F.) after 24h of in vitro culture with
10-8 M TPA. (c) CLL cells (case S.F.) after 48 h of in vitro culture with 10-9 M TPA. (d) CLL cells (case S.F.)
after 72h of in vitro culture with 1O-8M TPA. Note cellular heterogeneity, oval to elongated cell forrns,
increase of cell size and nucleus, eccentric nuclei, perinuclear clear zones, vacuolisation and protrusion of
cytoplasm in TPA-treated cells (Staining Wright-Giemsa; x 1000 magnification).
cell differentiation axis (Drexler et al., 1985a)
(Figure 3a). The monocyte-specific, sodium fluoride-
sensitive isoenzyme was not detected.
Acid phosphatase A stronger staining intensity of
one isoenzyme was seen in the TPA-treated cells
(Figure 3a). TPA induced the new expression of the
TracP isoenzyme in 4 cases and increased the
staining intensity of this particular isoenzyme in 2
cases which already expressed the band weakly
prior to induction.
Hexosaminidase Uninduced cells did not show any
isoenzymes (Fig. 3b). TPA induced the expression
of hexosaminidase isoenzymes A and B; isoenzyme
I was induced in 3 cases.
LDH By isoelectric focusing LDH isoenzymes 4
and 5 are divided into two components termed a
(acidic) and b (basic). A third component of
isoenzyme 5 which was found in mature T and B
leukaemia cell lines was termed 5c (Drexler et al.,
1985d). Non-treated CLL cells showed isoenzymes,
3, 4b, and 5b. TPA induced the new expression of
isoenzymes 2, 4a, 5a and Sc (Figure 3b).
No significant changes were found in the
isoenzyme profiles of the control cultures. Examples
of original gels showing isoenzyme profiles of TPA-
treated cells are given in Figure 4.
Discussion
In this study, we noted a rapid decrease of cell
number and viability in the untreated flasks
containing CLL control cells; less than 5% of the
originally seeded control CLL cells were viable at
days 8 and 10 of in vitro culture whereas the curve
of viable, TPA-treated (10-8M) CLL cells
plateaued at days 6-8 with a viability of 50% of
the original cell number. During days 0-4 the TPA-
exposed cultures contained mixed populations
consisting of small round cells and of enlarged cells
with other signs of maturation. At days 8 and 10
only the cells responding to TPA as evidenced by
their morphological features had survived while the
small round CLL cells which apparently were not
sensitive to TPA were no longer present.
These findings suggest that (a) about half of the
CLL cells responded to TPA-treatment with
maturation, and (b) only the 'responders' are able
to be maintained in in vitro culture whereas 'non-INDUCED DIFFERENTIATION OF B-CLL CELLS 185
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Figure 3 Schematic isoenzyme profiles of TPA-treated CLL cells at days 0-6 (no significant changes were
seen beyond day 6). (a) Left side: Carboxylic esterase; increase in staining intensity of isoenzymes and new
isoenzyme. Right side: Acid phosphatase; increase of staining intensity of one band and new expression of
TracP isoenzyme. (b) Left side: Hexosaminidase; new expression of isoenzymes A, I and B. Right
side: LDH; new expression of isoenzyme 2 and isoenzyme components 4a, 5a and c.
responders' and control cells cannot survive the
artificial environment of in vitro tissue culturing.
These suggestions are strengthened by the fact
that normal and malignant B cells can only be
'immortalized' and grown as continuous B lympho-
blastoid or B leukaemia/lymphoma cell lines after
infection with Epstein-Barr virus (EBV). On the
other hand, it was found that EBV induced pheno-
typic changes in B-CLL cells similar to those seen
after TPA-treatment (Deegan & Maeda, 1984).
After exposing CLL cells to TPA we noted
distinct changes in the cellular morphology with
cytoplasmic and nuclear enlargement, oval to
elongated cell forms, vacuolisation and protrusion
of cytoplasm, eccentric position of nuclei and
perinuclear clear zones. Whereas Deegan & Maeda
(1984) categorised the large cells resulting from
TPA-treatment as either plasmacytoid/plasmablastic
or as immunoblastic, Caligaris-Cappio et al. (1984)
noted that changes observed on TPA-induced CLL
cells resembled the morphology of hairy leukaemia
(HCL) cells.
Analysing the isoenzyme profiles of a large panel
of B cell leukaemia/lymphoma cell lines arrested at
different, but well-defined stages along the B-cell
axis, we could demonstrate an increase in number
and staining intensity of carboxylic esterase iso-
enzymes paralleling the assumed progression of
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Figure 4 Isoenzyme profiles of TPA-treated CLL cells (bottom anode, top cathode). (a) Carboxylic esterase
(case T.L., 10-8M TPA); stronger expression of several isoenzymes at days 2-4. (b) Acid phosphatase
(case A.H., 10-9M TPA); new expression of TracP and stronger staining of one band at days 2-4.
(c) Hexosaminidase (case S.F., 10-8M TPA); new expression of isoenzymes A, I and B at day 6. (d) LDH
(case T.L., 10-9 M TPA); new expression of isoenzyme 2 and isoenzyme components 4b, 5a and 5c at day 6.
differentiation (Drexler et al., 1985a). TPA initiated
stronger staining intensities of most esterase iso-
enzymes and the new expression of one isoenzyme
in the cultured CLL cells leading to an isoenzyme
profile as seen in B leukaemia cell lines of inter-
mediate to late stages of maturation.
Besides the increase of staining intensity of one
acid phosphatase band, the most prominent
changes in these isoenzyme profiles were the new
expression of the tartrate-resistant acid phosphatase
(TracP) isoenzyme. An increase in the total acid
phosphatase activity and the expression of TracP
has been demonstrated by other authors as well
using cytochemical assays (Al-Katib et al., 1984;
Caligaris-Cappio et al., 1984; Dufer & Bernard,
1984). However, it appears that isoelectric focusing
is a more sensitive technique for the detection of
the TracP isoenzyme than cytochemical methods as
this band was already found at day I in most cases
and at day 2 in all cases whereas the reaction was
cytochemically detectable at days 3-4 at the earliest
(Caligaris-Cappio et al., 1984; Al-Katib et al.,
1984). On one hand, TracP is a characteristic
marker of HCL (Yam et al., 1971); on the other
hand, using a panel of specific monoclonal anti-
bodies for the analysis of surface marker profiles in
comparison with other B cell malignancies,
Anderson et al. (1985) could show that HCL is a
'pre-plasma cell' malignancy. Therefore, the
expression of the TracP isoenzyme by the CLL cells
studied is further evidence for induced maturation
towards plasma cells.
Interestingly, in 3 out of 6 cases studied, the
isoenzyme I was newly induced. Hexosaminidase I
is on one hand a marker of early, immature
haematopoietic cells (Gaedicke & Drexler, 1984)
found predominantly in cALL, pre B-ALL, Null-
ALL and some very early acute myeloid
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leukaemias, but is on the other hand also seen in
fresh multiple myeloma cells (Drexler, unpublished
data) and in multiple myeloma cell lines (Drexler et
al., 1985c).
In studies reported elsewhere on the LDH
isoenzyme profiles of B leukaemia/lymphoma cell
lines, we observed a progressive increase in the
number of LDH isoenzymes expressed which
parallelled the progression of differentiation along
the B cell pathway (Drexler et al., 1985d). The
TPA-exposed B-CLL cells also exhibited an
increase in number and staining intensity of LDH
isoenzymes indicating induced B cell maturation.
The alterations of the various isoenzyme profiles
in CLL cells treated with TPA strongly suggest that
these cells were driven to more mature stages at
which these markers are normally represented. The
induced stages appear to correspond to those of
HCL cells or even later stages, and the cells might
be classified as 'pre-plasma cells' or 'plasmacytoid'.
Any phenotypic staging is of course only
approximate and artificial, and differentiation
represents a continuum of stages rather than clear-
cut categories (Gordon et al., 1984). It will be of
interest to identify and analyse the normal B cells
which are the normal counterparts or equivalents of
the TPA-treated B-CLL cells.
In summary, TPA could induce distinct morpho-
logical and isoenzymatic changes in B-CLL
indicative of differentiation along the B cell axis.
The induced alterations of the phenotype are
similar to those found in HCL and multiple
myeloma cells and might correspond to those of
'pre-plasma cells'. In vitro studies of induced cell
differentiation for leukaemia of B cell nature
provide useful information and new insights into
the biology of these malignancies and will extend
the understanding of normal B cell differentiation
processes.
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